• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Breast Lumps Between Mammography Visits Signal High Risk

  • in AJO · Audio · Oncology
  • — 19 Apr, 2018
Interval Breast Lumps signal cancer risk
DEEPENDRA SINGH
Breast Lumps Between Mammography Visits Signal High Risk
AudioMedica News
Breast Lumps Between Mammography Visits Signal High Risk
Breast Lumps Between Mammography Visits Signal High Risk
00:00 / 6 mins
Apple Podcasts Spotify Stitcher
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-3577"/>

Subscribe: Apple Podcasts | Spotify | Stitcher

BARCELONA—Women who develop breast symptoms—especially lumps—between regular mammography screening examinations are up to four times more likely to have a diagnosis of breast cancer soon after than women who do not have symptoms according to findings of a massive study of routine mammography from Finland reported at the 2018 European Breast Cancer Conference (EBCC 11).

“Women with symptoms should be taken as a different, separate group—a high risk group. So they will have different screening strategies from women without symptoms [with] more further assessment like ultrasound, further mammography or biopsy and close monitoring,” said study author Deependra Singh MPH who works in the Research Laboratory of the Finnish Cancer Registry in Helsinki, Finland.

ABSTRACT TITLE:

Breast symptoms and risk of interval breast cancers in mammography-screening programme 

https://www.ecco-org.eu/Events/EBCC11/Searchable-Programme#anchorScpr

You may also like...

  • John Gribben Normal stem cells are not depleted in acute myeloid leukaemia and could be targeted therapeutically 9 Aug, 2013
  • Audio Journal of Oncology Volume 16 Number 11 Audio Journal of Oncology Volume 16 Number 11 3 Jun, 2008
  • Chimeric antigen receptor T-cell therapy: high remission rate in relapsed, refractory acute lymphoblastic leukemia Chimeric antigen receptor T-cell therapy: high remission rate in relapsed, refractory acute lymphoblastic leukemia 19 Dec, 2013
  • PSA-membrane antibody conjugate shows promise for treating metastatic castration-resistant, taxane-refractory prostate cancer PSA-membrane antibody conjugate shows promise for treating metastatic castration-resistant, taxane-refractory prostate cancer 6 Feb, 2014

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Ribociclib Aids First-Line Endocrine Therapy in Premenopausal Advanced Breast Cancer
  • Next story Ultrahypofractionated Radiation Just As Effective for Prostate Cancer
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ribociclib Aids First-Line Endocrine Therapy in…
    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Polygenic Risk Scores Could Help Predict Second…
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • Oncology
  • AJO
  • Breast Lumps Between Mammography Visits Signal High Risk

© COPYRIGHT 2020 AUDIOMEDICA.COM.